This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Rensselaer Polytechnic Institute. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: **Elena Paskaleva: Pioneer in Biosynthetic Heparin Development**
Introduction
Elena Paskaleva, an innovative inventor based in Troy, NY, has made significant strides in the field of biochemistry with her unique contributions to heparin synthesis. Her work has not only advanced the understanding of synthetic alternatives to natural substances but has also opened doors to new medical applications.
Latest Patents
Elena holds one patent for her groundbreaking invention: biosynthetic heparin. This patent addresses the synthesis of heparin that can be bioequivalent to porcine USP Heparin Sodium. The process involves three intermediates starting from heparosan, showcasing her expertise in chemistry and innovation.
Career Highlights
Currently, Elena is affiliated with Rensselaer Polytechnic Institute. Her tenure at this reputable institution has allowed her to engage in research that is both impactful and relevant, contributing to the advancement of biomedicine.
Collaborations
Throughout her career, Elena has collaborated with esteemed colleagues, including Marc Douaisi and Navdeep Grover. These partnerships emphasize her commitment to teamwork and the collaborative spirit that drives innovation in research.
Conclusion
Elena Paskaleva’s work in the synthesis of biosynthetic heparin represents a noteworthy advancement in medical research. Through her patent and collaborative efforts, she continues to enhance the landscape of biochemistry and inspire future innovations in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile